DAVID ETTINGER: Open Payments
NPI 1598096018 · CORPUS CHRISTI, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,914 in 211 payments from 18 companies in 2025. Trend: 2023 $2,959 · 2024 $4,154 · 2025 $3,914
Food & beverage: $3,904Education: $10
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 33 | $561 |
| UCB, Inc. | 18 | $518 |
| Janssen Biotech, Inc. | 27 | $507 |
| Novartis Pharmaceuticals Corporation | 17 | $339 |
| LEO Pharma Inc. | 8 | $265 |
| Lilly USA, LLC | 9 | $229 |
| GENZYME CORPORATION | 11 | $216 |
| PFIZER INC. | 16 | $204 |
| E.R. Squibb & Sons, L.L.C. | 17 | $203 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 14 | $189 |
Products named: Bimzelx, TREMFYA, RINVOQ, DUPIXENT, SKYRIZI, Sotyktu, CIBINQO, COSENTYX.
Industry payments across TX — which companies pay providers there.
